Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interstitial lung disease in systemic sclerosis.

G S Cheema1, F P Quismorio

  • 1Division of Rheumatology and Clinical Immunology, Keck School of Medicine, University of Southern California, 2011 Zonal Avenue, Los Angeles, CA 90033, USA.

Current Opinion in Pulmonary Medicine
|October 5, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Somatic embryogenesis and plant regeneration from cell suspension and tissue cultures of mature himalayan poplar (Populus ciliata).

Plant cell reports·2013
Same author

Aplastic anemia secondary to azathioprine in systemic lupus erythematosus: report of a case with normal thiopurine S-methyltransferase enzyme activity and review of the literature.

Lupus·2013
Same author

A Geminivirus-Satellite Complex is Associated with Leaf Deformity of Mentha (Mint) Plants in Punjab.

Indian journal of virology : an official organ of Indian Virological Society·2013
Same author

Identification of new SLE-associated genes with a two-step Bayesian study design.

Genes and immunity·2009
Same author

Inverse association between circulating APRIL levels and serological and clinical disease activity in patients with systemic lupus erythematosus.

Annals of the rheumatic diseases·2004
Same author

Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.

Arthritis and rheumatism·2001

Systemic sclerosis frequently affects the lungs, causing interstitial lung disease (ILD). Early diagnosis via pulmonary function tests and prompt treatment, such as cyclophosphamide, can improve outcomes for this serious complication.

Area of Science:

  • Rheumatology
  • Pulmonology
  • Immunology

Background:

  • Systemic sclerosis (SSc) is a multisystem autoimmune disease with unknown etiology.
  • Pulmonary involvement, particularly interstitial lung disease (ILD), is a frequent and serious complication of SSc.
  • ILD in SSc is often under-recognized and diagnosed late, contributing to significant morbidity and mortality.

Purpose of the Study:

  • To review the pathogenesis, diagnosis, and treatment of interstitial lung disease in systemic sclerosis.
  • To highlight the importance of early diagnosis and intervention for pulmonary manifestations in SSc.
  • To discuss the role of cytokines and potential therapeutic strategies for SSc-ILD.

Main Methods:

  • Review of recent literature on systemic sclerosis and interstitial lung disease.

Related Experiment Videos

  • Discussion of diagnostic approaches including pulmonary function tests and bronchoalveolar lavage.
  • Analysis of the role of inflammatory and profibrotic cytokines in SSc-ILD pathogenesis.

    • Main Results:

    • Interstitial lung disease is a major cause of mortality and morbidity in systemic sclerosis.
    • Early diagnosis can be achieved through pulmonary function tests and bronchoalveolar lavage.
    • Profibrotic and inflammatory cytokines play a significant role in the pathogenesis of SSc-ILD.

    Conclusions:

    • Early diagnosis and treatment are crucial for managing interstitial lung disease in systemic sclerosis.
    • Cyclophosphamide, with or without corticosteroids, may be beneficial in arresting the progression of SSc-ILD.
    • Further research into the role of cytokines and novel therapies is warranted.